Challenges of an Open Access Screening Platform in Academia



August 22, 2012

  • Share
  • Edgar Specker, Head, Leibniz Institute of Molecular Pharmacology

    The lecture will describe the common workflow at the Screening Unit and the integration of the compound management system at our platform. It will give insights which show differences between an academic platform and an industrial set up exist. Additionally, our approach to collect compounds from academia will be discussed.

    Drug Discovery

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.